PAVmed (PAVM) EBT (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.13% |
| Sep 30, 2025 | 51.23% |
| Jun 30, 2025 | -166.18% |
| Mar 31, 2025 | 1,530.74% |
| Jun 30, 2024 | 19.44% |
| Mar 31, 2024 | -6.34% |
| Dec 31, 2023 | 19.96% |
| Sep 30, 2023 | -21.56% |
| Jun 30, 2023 | 19.46% |
| Mar 31, 2023 | 9.60% |
| Dec 31, 2022 | 17.91% |
| Sep 30, 2022 | -2.86% |
| Jun 30, 2022 | -48.22% |
| Mar 31, 2022 | 0.23% |
| Dec 31, 2021 | -43.98% |
| Sep 30, 2021 | -7.88% |
| Jun 30, 2021 | -25.32% |
| Mar 31, 2021 | -9.19% |
| Dec 31, 2020 | -57.63% |
| Sep 30, 2020 | -0.51% |
| Jun 30, 2020 | 60.81% |
| Mar 31, 2020 | -127.51% |
| Dec 31, 2019 | -100.37% |
| Sep 30, 2019 | 12.52% |
| Jun 30, 2019 | -0.94% |
| Mar 31, 2019 | 46.49% |
| Dec 31, 2018 | -111.13% |
| Sep 30, 2018 | 36.29% |
| Jun 30, 2018 | -82.15% |
| Mar 31, 2018 | -424.81% |
| Dec 31, 2017 | 116.96% |
| Sep 30, 2017 | -418.27% |
| Jun 30, 2017 | 76.82% |
| Mar 31, 2017 | -149.64% |
| Dec 31, 2016 | 11.31% |
| Sep 30, 2016 | -46.70% |
| Jun 30, 2016 | -88.66% |